All materials are supplied for laboratory research use only. Not for human or veterinary use.

Metabolic research

Synthetic peptides and small molecules that appear in metabolic and endocrine research literature. Every listing states its chemical identity and the nominal fill per vial. Laboratory research use only.

Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.

10 materials

Retatrutide research material packaging
Retatrutide

Retatrutide (LY3437943), synthetic GIP/GLP-1/glucagon receptor triagonist peptide

  • 5 mg
  • 10 mg
  • 15 mg
  • 20 mg
  • 30 mg
  • 40 mg
  • 50 mg
  • 60 mg

$56.00

Documentation pending

Tirzepatide research material packaging
Tirzepatide

Tirzepatide, synthetic GIP/GLP-1 receptor dual agonist peptide

  • 5 mg
  • 10 mg
  • 15 mg
  • 20 mg
  • 30 mg
  • 40 mg
  • 50 mg
  • 60 mg
  • 80 mg
  • 100 mg

$37.00

Documentation pending

5-Amino-1MQ research material packaging
5-Amino-1MQ

5-Amino-1MQ

  • 5 mg
  • 10 mg

$48.00

Documentation pending

Adipotide/FTTP research material packaging
Adipotide/FTTP

Adipotide/FTTP

  • 2 mg
  • 5 mg
  • 10 mg

$95.00

Documentation pending

AICAR research material packaging
AICAR

AICAR

  • 50 mg
  • 100 mg

$101.00

Documentation pending

Cagrilintide research material packaging
Cagrilintide

Cagrilintide

  • 5 mg
  • 10 mg

$123.00

Documentation pending

Dulaglutide research material packaging
Dulaglutide

Dulaglutide

  • 5 mg
  • 10 mg

$184.00

Documentation pending

Retatrutide + Cagrilintide research material packaging
Retatrutide + Cagrilintide

Retatrutide + Cagrilintide

  • 10 mg + 2 mg (12 mg total)
  • 20 mg + 4 mg (24 mg total)

$106.00

Documentation pending

Semaglutide research material packaging
Semaglutide

Semaglutide

  • 2 mg
  • 5 mg
  • 10 mg
  • 15 mg
  • 20 mg
  • 30 mg

$25.00

Documentation pending

Survodutide research material packaging
Survodutide

Survodutide

  • 10 mg

$319.00

Documentation pending